Stephanie Kielb
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Stephanie Kielb has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Alfred Rademaker
Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
2 shared publicationsEmily Rogalski
Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
2 shared publicationsSandra Weintraub
Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Department of Psychiatry and Behavioral Sciences, Division of Clinical Psychology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
2 shared publicationsAmanda Cook
Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois2Division of Clinical Psychology, Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medici
1 shared publicationChristina Wieneke
Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois
1 shared publicationEileen H. Bigio
Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois4Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
1 shared publication
Latest Publications
- 3 June 2017
- Published by Wiley in Alzheimer's & Dementia
- Vol. 13 (12) , 1337-1344
Objective features of subjective cognitive decline in a United States national database
Introduction: Functional and cognitive features of subjective cognitive decline (SCD) were identified in a longitudinal database from the National Alzheimer's Coordinating Center.Methods: Cognitively normal older adults with (SCD+) and without (SCD−) self‐reported memory complaints (N = 3915) were compared on (1) baseline Functional Assessment Questionnaire ratings, (2) baseline scores and longitudinal rate of change estimates from nine neuropsychological tests, and (3) final clinical diagnoses.Results: SCD+ had higher baseline ratings of functional impairment, reduced episodic memory practice effects and poorer performance on neuropsychological tests of psychomotor speed and language, and higher frequencies of mild cognitive impairment and dementia diagnoses at the end of follow‐up compared with the SCD‐group.Discussion: Subtle clinical features of SCD identified in this large cohort are difficult to detect at the individual level. More sensitive tests are needed to identify those with SCD who are vulnerable to cognitive decline and dementia.
- 3 June 2017
- Published by Wiley in Alzheimer's & Dementia
- Vol. 13 (12) , 1337-1344
Objective features of subjective cognitive decline in a United States national database
Introduction: Functional and cognitive features of subjective cognitive decline (SCD) were identified in a longitudinal database from the National Alzheimer's Coordinating Center.Methods: Cognitively normal older adults with (SCD+) and without (SCD−) self‐reported memory complaints (N = 3915) were compared on (1) baseline Functional Assessment Questionnaire ratings, (2) baseline scores and longitudinal rate of change estimates from nine neuropsychological tests, and (3) final clinical diagnoses.Results: SCD+ had higher baseline ratings of functional impairment, reduced episodic memory practice effects and poorer performance on neuropsychological tests of psychomotor speed and language, and higher frequencies of mild cognitive impairment and dementia diagnoses at the end of follow‐up compared with the SCD‐group.Discussion: Subtle clinical features of SCD identified in this large cohort are difficult to detect at the individual level. More sensitive tests are needed to identify those with SCD who are vulnerable to cognitive decline and dementia.
- Open Access
- 1 July 2016
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 73 (7) , 846-852
Neuropathologic Associations of Learning and Memory in Primary Progressive Aphasia
Primary progressive aphasia (PPA) is a neurodegenerative syndrome characterized by prominent language deterioration and early preservation of other cognitive abilities.1-3 Neuropathologically, PPA can be caused either by a variant of frontotemporal lobar degeneration (FTLD), usually either FTLD with TAR DNA-binding protein 43 proteinopathy or FTLD with tau proteinopathy (FTLD-tau), or by an atypical form of Alzheimer disease (AD) that initially spares episodic memory.4-6 More rarely, the syndrome has been associated with other neuropathologic entities, like Lewy body disease and Creutzfeldt-Jakob disease.7
- 1 July 2016
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 73 (7) , 846-852
Open AccessNeuropathologic Associations of Learning and Memory in Primary Progressive Aphasia
Primary progressive aphasia (PPA) is a neurodegenerative syndrome characterized by prominent language deterioration and early preservation of other cognitive abilities.1-3 Neuropathologically, PPA can be caused either by a variant of frontotemporal lobar degeneration (FTLD), usually either FTLD with TAR DNA-binding protein 43 proteinopathy or FTLD with tau proteinopathy (FTLD-tau), or by an atypical form of Alzheimer disease (AD) that initially spares episodic memory.4-6 More rarely, the syndrome has been associated with other neuropathologic entities, like Lewy body disease and Creutzfeldt-Jakob disease.7